最新文章：伊维菌素和芬苯达唑治疗见证——一位62岁的安大略省男子患有多发性骨髓瘤

最新文章：伊维菌素和芬苯达唑治疗见证——一位62岁的安大略省男子患有多发性骨髓瘤，3个月后报告病情缓解！多发性骨髓瘤是一种棘手的血液癌症，但我现在已经有好几个成功案例😃故事一名62岁的安大略省男子患有多发性骨髓瘤他服用了以下药物，持续了3个月：伊维菌素 1.0mg/kg/天芬苯达唑 1000 毫克/天D + VRD 诱导治疗（4 种药物组合，标准初始治疗）“开始D+VRD诱导治疗3个月后，包括您推荐的MM方案，他的M蛋白水平已无法测量。”“如果没有您的帮助，我相信我们无法走到今天这一步。”但事情还有变数：“XXX的癌症治疗团队正在努力推动患者在（干细胞）移植后再次接种疫苗。”接下来，这位癌症患者将不得不做出一些非常艰难的决定。重复接种疫苗极其危险。我就说到这儿吧。NEW ARTICLE: IVERMECTIN and FENBENDAZOLE Testimonial - 62 year old Ontario man with Multiple Myeloma reports after 3 months - remission!Multiple Myeloma is a tricky blood cancer, but I've now had several success stories 😃STORY62 year old Ontario man with Multiple MyelomaFor 3 months he took:Ivermectin 1.0mg/kg/dayFenbendazole 1000mg/dayD + VRD Induction (4 drug combination, standard initial treatment)"3 months after beginning D + VRD Induction, including your recommended MM Protocol, his M-Protein was unmeasurable""I do not believe we would be at this stage without your assistance".But there is a complication in this story:" XXX's cancer care team is pushing hard for re-vaccination post (stem cell) transplant"This is where this cancer patient will have to make some very difficult decisions. Re-vaccination is extremely dangerous. I'll leave it at that.